Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

November 04, 2022 16:03 ET | Source: NeuroPace, Inc.

NeuroPace to Present at the 4th Annual Wolfe Research Healthcare Conference

MOUNTAIN VIEW, Calif., Nov. 04, 2022 (GLOBE NEWSWIRE) -- NeuroPace, Inc. (Nasdaq: NPCE), a commercial-stage medical device company focused on transforming the lives of people living with epilepsy,...
October 25, 2022 16:03 ET | Source: NeuroPace, Inc.

NeuroPace to Report Third Quarter 2022 Financial Results on November 8, 2022

MOUNTAIN VIEW, Calif., Oct. 25, 2022 (GLOBE NEWSWIRE) -- NeuroPace, Inc. (Nasdaq: NPCE), a commercial-stage medical device company focused on transforming the lives of people living with epilepsy,...
August 23, 2022 16:06 ET | Source: NeuroPace, Inc.

NeuroPace to Present at the Morgan Stanley 20th Annual Global Healthcare Conference

MOUNTAIN VIEW, Calif. , Aug. 23, 2022 (GLOBE NEWSWIRE) -- NeuroPace, Inc. (Nasdaq: NPCE), a commercial-stage medical device company focused on transforming the lives of people living with epilepsy,...
August 11, 2022 16:02 ET | Source: NeuroPace, Inc.

NeuroPace Announces Distribution Agreement with DIXI Medical USA, Provider of Intracranial Electrodes and Instruments for Neurosurgery

MOUNTAIN VIEW, Calif., Aug. 11, 2022 (GLOBE NEWSWIRE) -- NeuroPace, Inc. (Nasdaq: NPCE), a commercial-stage medical device company focused on transforming the lives of people living with epilepsy,...
August 11, 2022 16:02 ET | Source: NeuroPace, Inc.

NeuroPace Reports Second Quarter 2022 Financial Results and Provides a Business Update

MOUNTAIN VIEW, Calif., Aug. 11, 2022 (GLOBE NEWSWIRE) -- NeuroPace, Inc. (Nasdaq: NPCE), a commercial-stage medical device company focused on transforming the lives of people suffering from...
July 21, 2022 16:03 ET | Source: NeuroPace, Inc.

NeuroPace to Report Second Quarter 2022 Financial Results on August 11, 2022

MOUNTAIN VIEW, Calif., July 21, 2022 (GLOBE NEWSWIRE) -- NeuroPace, Inc. (Nasdaq: NPCE), a commercial-stage medical device company focused on transforming the lives of people living with epilepsy,...
May 13, 2022 08:00 ET | Source: NeuroPace, Inc.

NeuroPace to Present at the 2022 RBC Capital Markets Global Healthcare Conference

MOUNTAIN VIEW, Calif., May 13, 2022 (GLOBE NEWSWIRE) -- NeuroPace, Inc. (Nasdaq: NPCE), a commercial-stage medical device company focused on transforming the lives of people suffering from epilepsy,...
May 12, 2022 16:03 ET | Source: NeuroPace, Inc.

NeuroPace Reports First Quarter 2022 Financial Results

MOUNTAIN VIEW, Calif., May 12, 2022 (GLOBE NEWSWIRE) -- NeuroPace, Inc. (Nasdaq: NPCE), a commercial-stage medical device company focused on transforming the lives of people suffering from epilepsy,...
April 21, 2022 16:03 ET | Source: NeuroPace, Inc.

NeuroPace to Report First Quarter 2022 Financial Results on May 12, 2022

MOUNTAIN VIEW, Calif., April 21, 2022 (GLOBE NEWSWIRE) -- NeuroPace, Inc. (Nasdaq: NPCE), a commercial-stage medical device company focused on transforming the lives of people suffering from...
March 10, 2022 16:02 ET | Source: NeuroPace, Inc.

NeuroPace Reports Fourth Quarter & Full Year 2021 Financial Results

MOUNTAIN VIEW, Calif., March 10, 2022 (GLOBE NEWSWIRE) -- NeuroPace, Inc. (Nasdaq: NPCE), a commercial-stage medical device company focused on transforming the lives of people suffering from...

keyboard_arrow_left Previous Page

Next Page keyboard_arrow_right